Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

42.43
Delayed Data
As of 4:02pm ET
 +0.32 / +0.76%
Today’s Change
37.41
Today|||52-Week Range
54.98
-0.52%
Year-to-Date
An Investing Overview of the Multiple Sclerosis Market
Jul 26 / MotleyFool.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2
Jul 25 / Zacks.com - Paid Partner Content
Investors Scour Big Pharma M&A Scene for Next Big Takeover
Jul 21 / TheStreet.com - Paid Partner Content
Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?
Jul 25 / Zacks.com - Paid Partner Content
Relypsa Finally Finds Buyer, But Potential Seen For Rival Bid
Jul 21 / TheStreet.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Why I Bought Shares of Regeneron Pharmaceuticals Inc. Last Week
Jul 20 / MotleyFool.com - Paid Partner Content
Actelion (ALIOF) Beats Q2 Earnings & Revenues, View Up
Jul 22 / Zacks.com - Paid Partner Content
Pfizer Publishes Final Data from Atopic Dermatitis Studies
Jul 14 / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Here's Why Regeneron Pharmaceuticals, Inc. Dropped Another 12% in June
Jul 13 / MotleyFool.com - Paid Partner Content
Benzinga's M&A Chatter for Thursday July 21, 2016:
Jul 21 / Benzinga - Paid Partner Content